Children News and Research

RSS

Scientists find strong genetic link to Crohn's disease

An international team of scientists believe they have identified a number of genes that may indicate a pre-disposal to developing Crohn's disease and say their discovery confirms the suspicion that the inflammatory bowel ailment has a strong genetic link.

17 Apr 2007

Overweight children more likely to need ear tubes

New research from scientists in South Korea suggests that obesity may be a factor in the risk of middle ear infections with fluid in children.

17 Apr 2007

New player in the development T-cell acute lymphoblastic leukemia

Leuven, Belgium -- Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year.

16 Apr 2007

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb Company has announced new results of the Baraclude (entecavir) resistance monitoring program, which found a continued low incidence of resistance in studies of nucleoside-naive chronic hepatitis B patients through four years of treatment.

16 Apr 2007

Essential medicines for children

Following recommendations from the Expert Committee on Essential Medicines, the World Health Organization (WHO) will immediately begin work to create a medicines list specifically tailored to children's needs. A group of experts will meet in July 2007 to produce the first international list of medicines to tackle diseases with high mortality and morbidity rates in children.

16 Apr 2007

Leukemic cells find safe haven in bone marrow

The cancer drug asparaginase fails to help cure some children with acute lymphoblastic leukemia (ALL) because molecules released by certain cells in the bone marrow counteract the effect of that drug, according to St. Jude investigators.

16 Apr 2007

Stranger than science fiction?...Human sperm created from bone marrow

A team of scientists have created primitive human sperm in the laboratory by using bone-marrow tissue from male volunteers.

16 Apr 2007

For teens - abstinence-only sex education programs...a waste of money!

It has taken a U.S. government report to confirm what experts in sexual behaviour have repeatedly warned about in recent years regarding teenage sex....abstinence just doesn't work.

16 Apr 2007

USAID provides assistance to Burkina Faso for outbreak of meningitis

The United States Government, through the U.S. Agency for International Development (USAID), will provide $450,000 through the U.S. Embassy in Ouagadougou to the UN Children's Fund (UNICEF) for vaccines urgently needed to maintain control of an outbreak of meningitis.

15 Apr 2007

Bullying widespread in elementary students

Nine out of 10 elementary students have been bullied by their peers, according to a simple questionnaire developed by researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.

15 Apr 2007

Ranbaxy receives U.S. approval to market Loratadine Antihistamine tablets

Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories Limited, has announced that Ranbaxy has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg. The antihistamine previously made the switch from the prescription to the OTC market.

15 Apr 2007

A report for the ten year strategy for the reduction of vitamin and mineral deficiencies

A new report by AED Center for Nutrition and the Global Alliance for Improved Nutrition (GAIN) for the Food and Nutrition Bulletin shows that while cost-effective interventions to reduce vitamin and mineral deficiencies have existed for more than 20 years, significant micronutrient deficiencies still plague many countries, increasing maternal and child mortality and slowing brain development in children.

15 Apr 2007

Eradicating polio a better option than extended control of the disease

Concerns about the high perceived costs of eradicating the relatively low number of polio cases worldwide have led to recent suggestions that it is time to shift from a goal of eradication to control—abandoning eradication and allowing wild poliovirus to continue to circulate, which proponents of control believe can sustain the low number of cases.

15 Apr 2007

Nationwide survey of state Medicaid programs on "pay-for-performance" practices

In the first published nationwide survey of state Medicaid programs on “pay-for-performance” practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care.

15 Apr 2007

Lupin Pharmaceuticals receives FDA approval for Suprax

Lupin Pharmaceuticals has announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for Suprax (Cefixime for oral suspension 200mg/5ml).

15 Apr 2007

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).

15 Apr 2007

Aftermath of suicide attempts - helping families cope

When a child attempts suicide, these emotions hit families like a Mack truck. Some family members bury their feelings deep inside and refuse to accept the stark reality.

15 Apr 2007

Asthma can lead to psychosocial disadvantages for children in our society

Much of the research surrounding childhood asthma has sought new approaches to managing the disease.

15 Apr 2007

FDA approves GlaxoSmithKline's antibacterial Altabax

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.

14 Apr 2007

FDA approves Altabax ointment for impetigo

The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.

14 Apr 2007